[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$foRhlHEnPkqf2fDF3-IHVJ0YYTvgagQwJy2b5I6S-vzI":8,"$ffbOl67-caW-3dFrdTm9EQGLiqK_0yE6KFKQjrUlh4Lk":55,"$f1UlYI7veQr_j6fI0smPTRXlATQnbMuugj5SVRlqhphE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65618,868966,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//Sn4y5XFopDyAUMV8myik3Yz75ketV11V.png","王坚楠","浙江大学医学院附属第一医院","甲状腺乳腺外科","主治医师",45,0,"乳腺癌术后辅助化疗 TCbHP方案：科学指导与实用建议","","https://ystcdn.venuertc.com/venue/AI/477a2d8a-7996-4b1c-8446-26f1623a86fb.jpg","\u003Cdiv id=\"material_title\" class=\"tcphp-title\">\n  乳腺癌术后辅助化疗 TCbHP方案：科学指导与实用建议\n\u003C/div>\n\u003Cdiv class=\"tcphp-intro\">\n  说起来，联合化疗和靶向药是乳腺术后常见的辅助治疗。TCbHP方案包含四种药品，分别有各自明确的剂型、化学成分和用药要求。本文将从7个实用细节出发，帮你快速掌握TCbHP方案中的药品特点、使用方法和安全注意点。不管是在医院接受静脉灌注，还是配合家庭健康管理，这些内容都能让用药更加安心和高效。\n\u003C/div>\n\u003C!-- 01 TCbHP方案的药品组成与作用机制 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 TCbHP方案包含哪些药品？机制如何发挥协同作用\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">💡\u003C/span>TCbHP方案是联合化疗与靶向药物方案，具体药品包括：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>\u003Cb>多西他赛\u003C/b>（T，Docetaxel）：紫杉类药物，通过抑制细胞微管的去聚合，阻断细胞分裂。\u003C/li>\n      \u003Cli>\u003Cb>卡铂\u003C/b>（Cb，Carboplatin）：烷化剂，破坏DNA链结构，干扰细胞复制和修复。\u003C/li>\n      \u003Cli>\u003Cb>帕妥珠单抗\u003C/b>（P，Pertuzumab）：靶向HER2受体，阻断信号通路，防止异常细胞增殖。\u003C/li>\n      \u003Cli>\u003Cb>曲妥珠单抗\u003C/b>（H，Trastuzumab）：同属单克隆抗体，攻击HER2表达细胞，促进免疫消除。\u003C/li>\n    \u003C/ul>\n    正确做法：每种药品都在医护环境下静脉给药，通过不同机制联合作用，增强抑制效果。需全程监控身体反应，尤其首剂后静观，以降低突发风险。\n    \u003Cdiv class=\"tcphp-data\">临床研究显示，曲妥珠单抗联合帕妥珠单抗和化疗药物，缓解率可达70%以上（Swain et al., 2015）。\u003C/div>\n  \u003C/div>\n\u003C/div>\n\u003C!-- 02 剂型特点和用药方法全解 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型特点及正确用法：每种药品怎么用？\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">🕑\u003C/span>TCbHP方案的剂型以静脉注射为主，但各药品用量和方法需分开处理：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>\u003Cb>多西他赛\u003C/b>：常见剂型为注射用浓溶液或冻干粉，每3周一次，剂量按体表面积计算。\u003C/li>\n      \u003Cli>\u003Cb>卡铂\u003C/b>：以注射用溶液方式静推，按AUC（面积下面积）与肾小球滤过率分别调整。\u003C/li>\n      \u003Cli>\u003Cb>帕妥珠单抗\u003C/b>：首次负荷剂量后进入维持阶段，每次剂量受体重等参数影响。\u003C/li>\n      \u003Cli>\u003Cb>曲妥珠单抗\u003C/b>：同样负荷剂量与维持剂量区分，给药间隔按医嘱制定。\u003C/li>\n    \u003C/ul>\n    正确做法：使用期间须提前检测肝肾功能及血象，每个疗程前评估身体状态。化疗当天应充分补水，主食以清淡为宜。\n    \u003Cspan class=\"tcphp-case-example\">临床上，60岁女性静注第4次TCbHP方案，因血小板低暂缓用药，表明骨髓抑制风险需及时干预。\u003C/span>\n  \u003C/div>\n\u003C/div>\n\u003C!-- 03 药物相互作用必须关注哪些细节？-->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物相互作用：哪些组合会有安全隐患？\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">⚠️\u003C/span>多个药品同时用，容易出现相互增强毒性的情况：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>\u003Cb>多西他赛\u003C/b>不要与酮康唑、伊曲康唑等强CYP3A4抑制剂同用，容易加重不良反应。\u003C/li>\n      \u003Cli>\u003Cb>卡铂\u003C/b>避免与氨基糖苷类抗生素等肾毒性药物合用，会增加肾损伤风险。\u003C/li>\n      \u003Cli>\u003Cb>帕妥珠单抗和曲妥珠单抗\u003C/b>禁止和蒽环类药物同用，心脏毒性显著增加。\u003C/li>\n    \u003C/ul>\n    正确做法：服药期间如需加用其他药物，必须事先与医生沟通，由药师审核后调整，无特殊批准不可随意叠加用药。\n  \u003C/div>\n\u003C/div>\n\u003C!-- 04 特殊人群用药与禁忌症管理 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 特殊人群和用药禁忌：哪些人要慎用？\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">🙋‍♀️\u003C/span>TCbHP方案不是人人适用，有明确的禁忌和需调整情况：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>明确对多西他赛、卡铂、帕妥珠单抗或曲妥珠单抗及其成分过敏者禁用。\u003C/li>\n      \u003Cli>孕妇、哺乳期妇女应避免用TCbHP方案。\u003C/li>\n      \u003Cli>严重肝肾功能不全、心力衰竭患者应停用。\u003C/li>\n      \u003Cli>老年人应定期评估肝肾心功能，根据检验结果微调剂量。\u003C/li>\n    \u003C/ul>\n    正确做法：如曾出现过敏反应，每次用药前遵循排查流程。如果身体状态发生明显改变，需快速告知医护团队停止相关药物。\n    \u003Cspan class=\"tcphp-case-example\">一位老年患者用TCbHP期间出现心慌不适，经评估减少药物剂量，顺利完成疗程。\u003C/span>\n  \u003C/div>\n\u003C/div>\n\u003C!-- 05 常见不良反应及处理办法 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应：出现这些变化怎么做？\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">🚨\u003C/span>多药联合方案经常带来一定的不良反应，表现包括：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>脱发、指甲色变、皮肤过敏、白细胞/血小板减少。\u003C/li>\n      \u003Cli>胃肠道反应，如恶心呕吐或腹泻。\u003C/li>\n      \u003Cli>肝功能波动，部分患者心脏功能异常，严重时心脏毒性。\u003C/li>\n    \u003C/ul>\n    数据显示，曲妥珠单抗相关心脏毒性发生率约5%（Perez et al., 2014）。\n    \u003Cdiv>\n      正确做法：\n      \u003Cul class=\"tcphp-list\">\n        \u003Cli>如感极度疲劳或出血倾向，要立即告知医护。\u003C/li>\n        \u003Cli>持续恶心、剧烈腹泻时及时处理水电解质平衡。\u003C/li>\n        \u003Cli>皮肤变色、脱发等物理变化可间断进行护理，无需强制停药。\u003C/li>\n        \u003Cli>若心慌、呼吸困难，需专科医生复查评估是否暂停药物。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cspan class=\"tcphp-case-example\">患者TCbHP期间短暂血小板减少，停药后恢复正常，整个疗程安全完成。\u003C/span>\n  \u003C/div>\n\u003C/div>\n\u003C!-- 06 储存方法及有效期管理 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药品储存要求和保存时限\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">🗃️\u003C/span>药品存放条件直接决定用药安全，每种药品需对应管理：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>\u003Cb>多西他赛、卡铂\u003C/b>注射液：避光、密封保存于25°C以下，开封后24小时内用完。\u003C/li>\n      \u003Cli>\u003Cb>帕妥珠单抗、曲妥珠单抗\u003C/b>：冷藏2~8°C，绝对禁冻，避免多次震荡。\u003C/li>\n    \u003C/ul>\n    正确做法：保留原厂包装，贴好药品标签，不可倒换到家用器皿；过期或残留药液按医疗废弃物交由专业处理，严禁自行丢弃或再次使用。\n  \u003C/div>\n\u003C/div>\n\u003C!-- 07 漏服与过量处理：如何应对用药意外 -->\n\u003Cdiv class=\"tcphp-section-bg\">\n  \u003Ch2 class=\"tcphp-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 漏服和过量情况处理办法\u003C/h2>\n  \u003Cdiv class=\"tcphp-content\">\n    \u003Cspan class=\"tcphp-emoji\">⏳\u003C/span>静脉化疗药物漏用或过量需特殊处理：\n    \u003Cul class=\"tcphp-list\">\n      \u003Cli>如漏服单剂，应迅速联系医生，由专科团队决定是否补用，不可自行调整时间和剂量。\u003C/li>\n      \u003Cli>发现用量超限立即停止用药，记录具体数量，并配合监护检查。\u003C/li>\n      \u003Cli>过量后密切观察生命体征，按指导补充支持治疗。\u003C/li>\n    \u003C/ul>\n    正确做法：化疗每次均由医护团队全程操作，无自行服用风险。如出现突发状况，详细告知用量和进度，协助紧急处置。\n  \u003C/div>\n\u003C/div>\n\u003C!-----结尾总结---->\n\u003Cdiv class=\"tcphp-summary\">\n  \u003Cspan class=\"tcphp-emoji\">✔️\u003C/span>\n  \u003Cb>小结：\u003C/b>TCbHP方案将多种药品联合应用，通过明确的剂型管理和科学的给药流程，有效减少耐药和并发症风险。关键细节在于严格遵循医生指导、重视药品储存与用药时间，以及及时发现和处置不良反应。只要做好这些环节，就能让辅助化疗更加安全高效。遇到任何疑问，请及时咨询专业医师或药师，合理用药才是健康保障的根本。\n\u003C/div>\n\u003C!-- 引用文献 -->\n\u003Cdiv class=\"tcphp-ref-bg\">\n  \u003Ch3 class=\"tcphp-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n  \u003Cul class=\"tcphp-ref-list\">\n    \u003Cli>\n      Swain, S. M., Baselga, J., Kim, S. B., Ro, J., Semiglazov, V., Campone, M., ... & Cortés, J. (2015). Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer (CLEOPATRA Study). \u003Ci>The New England Journal of Medicine\u003C/i>, 372(8), 724-734. \u003Ca href=\"https://doi.org/10.1056/NEJMoa1413513\" target=\"_blank\">https://doi.org/10.1056/NEJMoa1413513\u003C/a>\n    \u003C/li>\n    \u003Cli>\n      Perez, E. A., Spano, J. P., Cardoso, F., et al. (2014). Cardiac Safety of Pertuzumab Plus Trastuzumab With and Without Anthracyclines. \u003Ci>Annals of Oncology\u003C/i>, 25(8), 1698-1703. \u003Ca href=\"https://doi.org/10.1093/annonc/mdu182\" target=\"_blank\">https://doi.org/10.1093/annonc/mdu182\u003C/a>\n    \u003C/li>\n  \u003C/ul>\n\u003C/div>\n\u003Cstyle>\n.tcphp-title {\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', sans-serif;\n  font-size: 36px;\n  color: #115c83;\n  font-weight: bold;\n  text-align: center;\n  margin-top: 30px;\n  margin-bottom: 30px;\n  letter-spacing: 2px;\n  background: linear-gradient(90deg,#e3f5ff 80%,#f8fbfd 100%);\n  border-radius: 18px;\n  padding: 30px 20px;\n  box-shadow: 0 4px 12px #eaf6fe;\n}\n.tcphp-intro {\n  font-size: 20px;\n  color: #333;\n  background: #f2f7fc;\n  border-left: 6px solid #79b5db;\n  padding: 22px 30px;\n  margin-bottom: 32px;\n  border-radius: 16px;\n}\n.tcphp-section-bg {\n  background: url('data:image/svg+xml;utf8,\u003Csvg%20width%3D%22200%22%20height%3D%2290%22%20xmlns%3D%22http%3A//www.w3.org/2000/svg%22>\u003Crect%20width%3D%22100%25%22%20height%3D%22100%25%22%20fill%3D%22%23eef7fa%22/>\u003Ccircle%20cx%3D%2228%22%20cy%3D%2240%22%20r%3D%2212%22%20fill%3D%22%23b8e4fb%22/>\u003Ccircle%20cx%3D%22120%22%20cy%3D%2250%22%20r%3D%227%22%20fill%3D%22%23e2f0fa%22/>\u003C/svg>');\n  background-size: 200px 90px;\n  background-repeat: repeat-x;\n  padding: 35px 32px 28px 32px;\n  margin-bottom: 36px;\n  border-radius: 15px;\n  box-shadow: 0 2px 8px #e6eef4;\n}\n.tcphp-section-title {\n  font-size: 28px;\n  color: #195673;\n  font-weight: 600;\n  margin-bottom: 18px;\n  text-shadow: 1px 1px 0 #c4e7ff;\n  padding-left: 10px;\n}\n.tcphp-content {\n  font-size: 19px;\n  color: #212b36;\n  line-height: 2.1em;\n  padding-left: 15px;\n  padding-right: 10px;\n}\n.tcphp-list {\n  padding-left: 24px;\n  margin-top:10px;\n  margin-bottom:10px;\n}\n.tcphp-list li {\n  margin-bottom:10px;\n  font-size:18px;\n  color:#155085;\n  background: #edf6fa;\n  border-radius: 8px;\n  padding: 8px 10px 8px 15px;\n}\n.tcphp-emoji {\n  font-size: 1.4em;\n  margin-right: 10px;\n  vertical-align: middle;\n}\n.tcphp-data {\n  display: block;\n  margin-top:14px;\n  background:#d6eaf9;\n  color:#134d73;\n  padding: 11px 20px;\n  border-radius: 8px;\n  font-size:17px;\n  font-style:italic;\n  box-shadow: 0 2px 6px #b7c9d0;\n}\n.tcphp-case-example {\n  display:block;\n  margin-top:18px;\n  background:#fcf3dd;\n  color:#8c6e2c;\n  border-left: 4px solid #f7d574;\n  padding:9px 15px;\n  border-radius:7px;\n  font-size:17px;\n  font-weight: 500;\n}\n.tcphp-summary {\n  background:linear-gradient(90deg,#e7f1c7 60%,#f6f9e1 100%);\n  font-size: 22px;\n  color: #194c26;\n  font-weight: 500;\n  padding:24px 32px;\n  margin:35px 0 25px 0;\n  border-radius: 12px;\n  box-shadow:0 3px 8px #eaeeca;\n}\n.tcphp-ref-bg {\n  background:#f1f7fa;\n  border-top:2px solid #abcbe8;\n  margin-top:30px;\n  padding:20px 31px 10px 31px;\n  border-radius:10px;\n  box-shadow:0 4px 14px #d8e5ee;\n}\n.tcphp-ref-title {\n  font-size:22px;\n  color:#146392;\n  font-weight:600;\n  margin-bottom:15px;\n}\n.tcphp-ref-list {\n  font-size:18px;\n  color:#173850;\n  padding-left:26px;\n}\n.tcphp-ref-list li {\n  margin-bottom:10px;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"tcphp-title\">\n  乳腺癌术后辅助化疗 TCbHP方案：科学指导与实用建议\n\u003C/div>\n\u003Cdiv class=\"tcphp",520,"2025-09-03 17:36:09","TCbHP, 乳腺癌, 辅助化疗, 用药安全, 不良反应","了解TCbHP方案，结合化疗与靶向药物的具体用药方法、安全注意事项，为乳腺癌术后患者提供科学的治疗指导和实用建议，助力康复。阅读后掌握用药要点，提升安全性与效果。","2025-09-08 14:05:10",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]